Theranostic mesoporous platinum nanoplatform delivers halofuginone to remodel extracellular matrix of breast cancer without systematic toxicity

[1]  P. Dickman,et al.  Cancer survival statistics for patients and healthcare professionals – a tutorial of real‐world data analysis , 2020, Journal of internal medicine.

[2]  Guangming Lu,et al.  Computed tomography and photoacoustic imaging guided photodynamic therapy against breast cancer based on mesoporous platinum with insitu oxygen generation ability , 2020, Acta pharmaceutica Sinica. B.

[3]  I. Sagi,et al.  Emerging roles of ECM remodeling processes in cancer. , 2020, Seminars in cancer biology.

[4]  N. Frangogiannis.  Transforming growth factor–β in tissue fibrosis , 2020, The Journal of experimental medicine.

[5]  J. Tao,et al.  Mesoporous platinum nanoparticle-based nanoplatforms for combined chemo-photothermal breast cancer therapy. , 2020, Journal of colloid and interface science.

[6]  Qiang Zhang,et al.  Melanin-like nanoparticles loaded with an angiotensin antagonist for an improved photothermal cancer therapy. , 2020, Biomaterials science.

[7]  Shibo Wang,et al.  Remodeling extracellular matrix based on functional covalent organic framework to enhance tumor photodynamic therapy. , 2020, Biomaterials.

[8]  Kenneth M. Yamada,et al.  Extracellular matrix dynamics in cell migration, invasion and tissue morphogenesis , 2019, International journal of experimental pathology.

[9]  V. Weaver,et al.  The Extracellular Matrix Modulates the Metastatic Journey. , 2019, Developmental cell.

[10]  T. Stylianopoulos,et al.  Accumulation of mechanical forces in tumors is related to hyaluronan content and tissue stiffness , 2018, PloS one.

[11]  J. Chirgwin,et al.  Halofuginone inhibits TGF-β/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis , 2017, Oncotarget.

[12]  Ping Wang,et al.  Inhibition of TGF-β signaling with halofuginone can enhance the antitumor effect of irradiation in Lewis lung cancer , 2015, OncoTargets and therapy.

[13]  Catherine C. Park,et al.  Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration. , 2015, Integrative biology : quantitative biosciences from nano to macro.

[14]  M. Pines,et al.  Halofuginone — The Multifaceted Molecule , 2015, Molecules.

[15]  M. Pines.  Halofuginone for fibrosis, regeneration and cancer in the gastrointestinal tract. , 2014, World journal of gastroenterology.

[16]  R. Jain,et al.  TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma , 2012, Proceedings of the National Academy of Sciences.

[17]  Carlos Cuevas,et al.  Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. , 2012, Cancer cell.

[18]  R. Jain,et al.  Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors , 2011, Proceedings of the National Academy of Sciences.

[19]  D. Lacombe,et al.  Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours. , 2006, European journal of cancer.

[20]  K. Kalia,et al.  Tumor Microenvironment Targeted Nanotherapeutics for Cancer Therapy and Diagnosis: A review. , 2019, Acta biomaterialia.

[21]  Young Hun Kim,et al.  Halofuginone induces the apoptosis of breast cancer cells and inhibits migration via downregulation of matrix metalloproteinase-9. , 2014, International journal of oncology.